Elie Naddaf, M.D., a consultant in the Department of Neurology, took an unusual and exciting next step in his career — he ...

The Trump administration has reportedly disrupted over 100 clinical trials. Science News spoke to researchers about the impacts on four of them.

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been ...

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

InhaleRX (ASX:IRX) has taken a crucial step to initiate research into IRX-616a – the drug candidate it’s developing to treat ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

A multinational research team of clinicians and scientists from South Korea and Singapore has published positive findings ...

At UChicago, she now works under Prof. Jeffrey Hubbell on a new method to improve cancer therapy. Using genetic instructions ...

Both studies, which are reporting the results of early-stage clinical trials, show that the interventions were safe, and that ...

Sessions addressing supportive care needs for patients with cancer on early phase clinical trials appeared feasible and acceptable in a prospective study.

Initiation by Merck of a Phase 2 trial in Alzheimer’s disease with partnered α7 nicotinic acetylcholine receptor PAM MK-1167 highlights company’s ...

Jonathan Kimmelman, PhD, has published multiple research papers and gotten into an inordinate number of debates about the clinical value of phase 1 trials.“I’ve argued for a long time that for phase 1 ...